Olaplex, a well-known hair care brand famous for its bond-building treatments and rejuvenating formulas, has been the subject of multiple lawsuits saying its products caused adverse side effects, including hair loss and scalp irritation. Additionally, the company faced legal challenges over alleged false advertising claims, particularly around labeling that products were “Made in the USA.” This article provides a comprehensive overview of the lawsuit’s background, major allegations, company responses, settlement details, and what affected consumers need to know.
Olaplex Lawsuit
Background of the Olaplex Lawsuit
The initial wave of lawsuits against Olaplex began in early 2023 when a number of consumers reported hair loss, scalp irritation, and bald spots linked to the use of Olaplex haircare products. These complaints led to a civil lawsuit filed by Jessica Auriana and over twenty other women in California, seeking compensation for damages caused by the alleged harmful effects of Olaplex products.
In addition to the hair loss and burn allegations, another major legal front concerned false labeling. In April 2024, Olaplex was sued in a class action case for misleading consumers by labeling its products as “Made in USA” while they contained various foreign-made ingredients, breaking California’s consumer protection laws.
Main Allegations
The plaintiffs’ claims contain several core allegations:
- Product Safety Concerns: Olaplex products caused hair loss, scalp burns, rashes, and bald patches in users. The products allegedly include harsh chemicals not sufficiently disclosed affecting consumer health.
- False Advertising: Olaplex falsely advertised that its products were made entirely in the United States when sizable portions of ingredients were imported.
- Failure to Warn: The company allegedly did not warn users about potential risks such as allergic reactions or scalp damage.
- Emotional Distress: Plaintiffs claim suffering significant emotional and psychological distress due to hair loss and injuries.
Legal Proceedings
In July 2023, a judge denied the request to certify the case as a class action lawsuit due to the varied experiences of plaintiffs and differing claims, causing the dismissal of all but the first named plaintiff’s claims, which were later voluntarily dropped.
Despite these setbacks, other individual lawsuits continue, and ongoing investor lawsuits allege the company withheld information about product safety issues and financial problems, which impacted stock prices negatively in late 2022 and early 2023.
Settlement Information
The class action related to the “Made in USA” labeling reached a settlement agreement. The settlement period closed on May 12, 2025. Eligible consumers who purchased Olaplex products bearing the “Made in USA” or similar statements between February 7, 2019, and September 6, 2024, were offered a $5 voucher redeemable on Olaplex’s website as compensation. This voucher is not redeemable for cash and expires 12 months after issuance.
The settlement does not include cash payouts and requires claimants to submit valid claims before the deadline to receive the vouchers. There is only one voucher per person regardless of the number of products purchased.
Company’s Response
Olaplex has consistently denied all wrongdoing, stating that their products are safe and meet all regulatory standards. The company highlighted independent laboratory testing and quality controls as part of their defense. Regarding the “Made in USA” claim, Olaplex said the labeling and marketing were done in good faith and aligned with regulatory guidelines.
Olaplex also emphasized ongoing commitments to transparency, innovation, and consumer safety in its public communications following the lawsuits.
Investor Lawsuit Settlement
Alongside consumer lawsuits, Olaplex agreed to settle investor-related claims in August 2025. The investor lawsuit alleged that the company misled shareholders about the safety profile of its products and overstated financial performance, leading to significant stock price declines.
The settlement resolves these claims, allowing investors who purchased Olaplex stock between September 30, 2021, and January 17, 2023, to file claims for possible compensation.
What Consumers Should Do
- Consumers experiencing hair loss, scalp irritation, or related symptoms after Olaplex use should consult medical professionals and document their symptoms carefully.
- Check eligibility for the “Made in USA” settlement if Olaplex products were purchased during the class period and submit claims before the deadline if possible.
- Stay informed about ongoing legal developments and future litigation, as additional suits or settlements may arise.
Conclusion
The Olaplex lawsuit spotlighted important issues in the personal care industry involving product safety, truthful marketing, and consumer rights. Although some legal hurdles have been reached, Olaplex remains under legal scrutiny with multiple cases ongoing. Consumers and investors alike should stay informed and consider their legal options if impacted.
